CG-P5 peptide eye drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CG-P5 peptide eye drops, covering 2025-02-07 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration [Phase 1]